Federal contract award
75N93019C00055
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2021
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $33.2M |
| Current contract value | $33.2M |
| Potential contract value / ceiling | $210.6M |
| Start date | Sep 16, 2019 |
| Current end date | Sep 15, 2030 |
| Potential end date | Sep 15, 2030 |
| Latest award activity | Aug 11, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 30 of 30 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 11, 2026 | P00029 | $0 | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE |
| Sep 26, 2025 | P00028 | $2.9M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE |
| Sep 15, 2025 | P00027 | $83.2K | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE |
| Aug 18, 2025 | P00026 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Jul 14, 2025 | P00025 | $767.3K | EOI::14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Apr 14, 2025 | P00024 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Sep 13, 2024 | P00023 | $305.7K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Aug 15, 2024 | P00022 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Jun 25, 2024 | P00021 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Apr 19, 2024 | P00020 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Feb 20, 2024 | P00019 | $944.5K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Jan 30, 2024 | P00018 | $1.2M | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Dec 11, 2023 | P00017 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Aug 25, 2023 | P00015 | $848.9K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Aug 16, 2023 | P00014 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Jul 20, 2023 | P00013 | $866.9K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Apr 21, 2023 | P00012 | $1.4M | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Mar 13, 2023 | P00011 | $5.0M | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Jan 27, 2023 | P00010 | $305.7K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Oct 24, 2022 | P00009 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Sep 14, 2022 | P00016 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Jul 25, 2022 | P00008 | $828.8K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Jun 8, 2022 | P00007 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Nov 14, 2021 | P00006 | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Aug 25, 2021 | P00005 | $1.3M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - AUGUST 20, 2025 |
| Jun 29, 2021 | P00004 | $810.6K | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2022 |
| Feb 22, 2021 | P00003 | $1.6M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2022 |
| Aug 13, 2020 | P00002 | $4.2M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2022 |
| Jun 25, 2020 | P00001 | $7.4M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2021 |
| Sep 16, 2019 | 0 | $2.6M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2021 |
Estimated positioning window
Sep 15, 2029 – Mar 15, 2030
Recompete signal: . Rule-based research score; positioning dates are estimates.
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2030-09-15 (1414 days from calculation)
- +5 points
- 155 historical awards in this buyer and category group
- +15 points
- 30 recorded award transactions
- +10 points
- Latest award action: 2026-08-11
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.